help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology, doi:10.1210/en.2005-0604
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Campbell, B. K.
Right arrow Articles by Baird, D. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Campbell, B. K.
Right arrow Articles by Baird, D. T.
Endocrinology Vol. 147, No. 4 1608-1620
Copyright © 2006 by The Endocrine Society

Enhanced Response of Granulosa and Theca Cells from Sheep Carriers of the FecB Mutation in Vitro to Gonadotropins and Bone Morphogenic Protein-2, -4, and -6

B. K. Campbell, C. J. H. Souza, A. J. Skinner, R. Webb and D. T. Baird

Department of Obstetrics and Gynaecology (B.K.C., A.J.S.), Queen’s Medical Centre, University of Nottingham, Nottingham NG7 2UH, United Kingdom; Embrapa Pecuaria Sul (C.J.H.S.), Bage RS 96401-970, Brazil; School of Biosciences (R.W.), Sutton Bonington Campus, University of Nottingham LE12 5RD, United Kingdom; and Centre for Reproductive Biology (D.T.B.), University of Edinburgh, Edinburgh EH16 4SA, Scotland, United Kingdom

Address all correspondence and requests for reprints to: B. K. Campbell, School of Human Development, University of Nottingham, D Floor, East Block, Queen’s Medical Centre, Nottingham NG7 2UH, United Kingdom. E-mail: bruce.campbell{at}nottingham.ac.uk.


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The FecB (Booroola) mutation, which leads to increased ovulation rates and multiple births in sheep, is now known to occur in the signaling domain of the bone morphogenic protein (BMP)-1B receptor. We examined the effect of the mutation on the responsiveness of granulosa (GC) and theca cells (TC) to BMPs and other local regulators using tissue from animals with (FecB/B) and without (Fec+/+) the FecB mutation. Experiments examined the effect of BMP-2, -4, and -6 (0.005–50 ng/ml), and their interaction with IGF-I (0.1–10 ng/ml LR3 analog) and gonadotropins, on the proliferation and differentiation of GCs and TCs isolated from small (<2 mm) antral follicles and maintained in serum-free culture for up to 8 d. Dose-finding studies using ovaries from wild-type sheep obtained from the abbattoir showed no difference among the different BMPs in stimulating (P < 0.001) estradiol (E2) production by GCs cultured with FSH (10 ng/ml), but there was a clear interaction (P < 0.001) with IGF-I. BMPs had no effect on GC proliferation or the sensitivity of GCs to FSH. In contrast, higher doses of BMPs (5–50 ng/ml) inhibited LH-stimulated androstenedione production by TCs, whereas lower doses (0.005–0.05 ng/ml) stimulated TC proliferation (P < 0.01). Regardless of dose of IGF-I, at the end of culture (96–192 h) hormone production by GCs (E2, inhibin A) and TCs (androstenedione) was 4- to 5-fold greater (P < 0.001) by cells from FecB/B, compared with Fec+/+ ewes exposed to the same dose of gonadotropin. In the presence of low concentrations of IGF-I (0.1 ng/ml), the maximum increase in the production of E2 and inhibin A by GCs from FF ewes in response to BMPs was observed at doses that were 3- to 10-fold lower (3–10 ng/ml) than ++ (30 ng/ml; P < 0.001). Low doses of BMPs stimulated proliferation of TCs from ++ (P < 0.01) but not FF ewes. Immunohistochemistry confirmed BMP-6 protein expression in the oocyte, granulosa, and thecal layers of antral follicles from both genotypes. These results confirm a major role for BMPs in controlling ovarian somatic cell function in sheep and provide evidence to support the hypothesis that the FecB mutation increases the BMP response of somatic cells when stimulated to differentiate by gonadotropins.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
THE FecB (Booroola) mutation in sheep results in dysregulation of the normal mechanisms of follicle selection in this species and has been the subject of intensive research for more than 30 yr (1, 2, 3). The recent discovery that this (4, 5, 6) and other multiovulatory phenotypes are due to mutations in components of the bone morphogenic protein (BMP) system (2, 7) suggests that this system may be one of the main ways in which follicle selection is regulated in monovulatory species. Whereas the exact mechanisms regulating the selection of ovulatory follicles from a much larger follicular cohort remain to be fully elucidated, it is thought that the basis of both recruitment and selection lies in the pattern of gonadotrophic stimulation received by the ovary and intrafollicular factors that modulate gonadotrophic actions (8, 9, 10, 11). Over the last decade, intensive research in this area has led to the identification of a number of key local regulators such as the IGF (2) and inhibin/activin (3) systems, that have been shown to modulate the sensitivity of follicular somatic cells to gonadotropins and are therefore considered to be central to the mechanism of follicle selection. Recent research has identified BMPs as other potentially important local factors that may interact with the other well-described regulators.

To date, most studies examining the role of the BMP system in ovarian physiology have been performed in polyovular rodents (12, 13, 14). The mRNAs encoding BMP-2, -3, -3b, -4, -6, -7, -15, growth differentiation factor (GDF)-9, and BMP receptor (BMPR)-IA, BMPR-IB, and BMPR-II have been identified in the ovary in various mammals (12). In rats, BMP-4 and -7 have been shown to colocalize to the theca interstitial cells and expression levels for both BMPs change during folliculogenesis (14). In the mouse, BMP-6 is expressed at high levels in immature and mature oocytes and at lower levels in the granulosa cells (15). The expression of BMP-15 (15, 16, 17, 18, 19) and GDF-9 (15, 17) is confined exclusively to the oocyte in most species studied. In human ovaries, BMP-3 mRNA is strongly detectable by Northern analysis, whereas BMP-2 mRNA level is low and BMP-3b undetectable (20). The rat (14), bovine (21), and sheep (22) ovary has also been shown to be a major site of BMPR-I and -II expression, supporting the hypothesis that BMPs are important to ovarian physiology. Cell culture studies in rats have shown that both BMP-4 and -7 caused an increase in FSH-induced estradiol production but a decrease in FSH-induced progesterone production (14). BMP-6 was also found to be potent in the attenuation of FSH-induced progesterone production; however, in contrast to BMP-4 and -7, BMP-6 did not alter FSH-induced estradiol production (23). BMP-15 is a potent stimulator of GC proliferation (18) and inhibitor of FSH receptor expression in rat granulosa cells (24). In contrast, GDF-9 promotes GC proliferation and inhibits FSH-induced steroidogenesis and LH receptor expression (25).

In sheep, naturally occurring genetic mutations in several components of the BMP system have been shown to induce increases in ovulation rate. In Inverdale (FecXI) and Hanna (FecXH) ewes, separate point mutations were identified in the BMP (BMP-15) gene on the X chromosome corresponding to sites in the mature peptide coding region of the BMP15 growth factor (26). A remarkable characteristic of these mutations is that those that are heterozygous for the FecXI or FecXH mutation have higher-than-normal ovulation rates and litter sizes, whereas the homozygotes are sterile (27). Similarly, in Cambridge and Belclare ewes, mutations in both BMP-15 and the closely related GDF-9 lead to marked increases in ovulation rate (28). In contrast, in Booroola (FecB), Garole (FecB), and Javanese (FecB) sheep, a point mutation has been identified in the highly conserved intracellular serine threonine kinase signaling domain of the BMPR-IB on chromosome 6 (4, 5, 6, 29). In FecB animals, a single A to G transition occurs at nucleotide position 830, thereby substituting an arginine for glutamine at position 249 of the protein. The consequences of this mutation are that heterozygote females have an ovulation rate around one or two times higher than the noncarriers, and homozygotes (FF) have ovulation rates around three to 10 times higher than noncarriers (1, 7), but the mechanisms underlying this effect are unknown.

The FecB mutation results in a dysregulation of the follicle selection mechanisms with the precocious development of a large number of small antral follicles, leading to the greatly increased ovulation rates and multiple births (30, 31, 32). Although the identity of the FecB mutation is now known, a major question remains in terms of whether the mutation acts at the level of the ovary or the pituitary. The BMPR-1B is expressed by the pituitary (5) in sheep, and a number of investigators have reported increased FSH in ewes with the FecB mutation (33, 34). Conversely, mRNA (5) and protein (4) expression for type I and II BMPRs has been demonstrated in sheep ovarian somatic and germ cells, and BMP-2 (22), BMP-4, and GDF-5 (6) have all been shown to modulate steroid production by sheep granulosa cells in culture. We recently examined this question using ovarian autotransplants with and without the FecB mutation treated with a potent GnRH antagonist for 3 wk to render the animals hypogonadotrophic and then stimulated with the same gonadotropin regimen designed to mimic the normal pattern of FSH and LH during the follicular phase (35). In this study, the difference in ovulation rate and the characteristic phenotype of smaller ovulatory follicles and corpus luteum was retained, providing strong evidence that the FecB mutation acts at the level of the ovary to modulate gonadotrophic responsiveness.

The current evidence therefore suggests that BMPs can augment FSH-stimulated granulosa cell differentiation in sheep, and this is a possible mechanism to explain the effect of the FecB mutation in inducing precocious maturation of ovarian follicles. However, much more work is needed to identify the physiological ligands of the ovarian BMPRs and determine their relative actions, potencies, and interactions with other local modulators in the control of ovarian somatic cell differentiation in monovulatory species. Furthermore, the effect of the FecB mutation on the responsiveness of granulosa and theca cells to stimulation by gonadotropins, BMPs, and other local regulators needs to be determined to understand how a single mutation can have such a profound effect on ovarian function. The aim of the current work was to examine these questions using serum-free culture systems for both sheep granulosa (36) and theca (37) cells, which allow induction of cellular differentiation in vitro in response to physiological doses of gonadotropins and local factors over time frames that parallel those observed for similar processes in vivo. The specific hypothesis being investigated was that the FecB mutation would result in an alteration in the sensitivity of ovarian granulosa and thecal cells to stimulation with gonadotropins (FSH/LH), BMPs, and other established differentiative (IGF-I) and proliferative (TGF{alpha}) growth factors.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Experimental animals
Experiments were conducted in accordance with the Animal (Scientific Procedures) Act of 1986 (United Kingdom). For experiments examining the effect of the FecB mutation, experimental animals were Scottish Blackface Merino cross ewes obtained from an experimental flock that had been derived in such a way that the animals differed at the Booroola locus (being either Fec+/+ or FecB/B) but were as similar as possible for the rest of the genome to provide experimental material with little risk of biased comparisons (38). The animals were run under field conditions and fed a maintenance diet consisting of concentrates and hay ad libitum. Ovarian tissue was collected during the midbreeding season on d 4–10 of the estrous cycle following synchronization using progestagen sponges (medroxyprogesterone-acetate; Dunlop, Dumfries, UK) and cloprostenol (Estrumate, Dunlop) as previously described (39). FecB animals were killed by anesthetic overdose and both ovaries recovered by midventral incision under sterile conditions. For dose-finding studies, ovaries were obtained from the local abbattoir, following stunning and exsanguination, as previously described (36). For expression studies, ovarian tissue was immediately fixed in 4% paraformaldehyde following excision, whereas for culture studies the ovaries were placed in dissection medium (see below) at 37 C.

Hormones and reagents
Human recombinant BMP-2, -4, and -6 for in vitro studies were obtained from Sigma-Aldrich (Poole, Dorset, UK). Mouse antihuman BMP-6 was obtained from Chemicon Europe (Hampshire, UK). Ovine (o) FSH and LH were obtained from the National Institutes of Health. All other reagents were obtained from Sigma-Aldrich unless otherwise stated.

Expression of BMP-6 protein in the sheep ovary
Ovaries from wild-type and FecB mutant animals were fixed overnight in freshly prepared 4% paraformaldehyde in PBS (pH 7.4), and after fixation, ovaries were cut longitudinally in two or four slices, care being taken to cut through the largest follicles on each ovary (40). The tissue was then dehydrated by passage through a graded series of alcohols and embedded in paraffin wax.

Immunohistochemistry
Ovarian 5-µm sections on SuperFrost Plus microscope slides (Menzel-Glaser, Braunschweig, Germany) were dewaxed in xylene for 2 x 3 min and rehydrated in decreasing concentrations of alcohol (90, 70, 30, and distilled water), followed by two washes of 5 min each in 0.01 M PBS (pH 7.4). Antigen retrieval was carried out by microwaving the sections in preboiled citrate buffer [0.01 M (pH 6.0)] in an 800-W microwave at 50% power for 15 min. The slides were then left to rest in the buffer for 20 min until cool. After two 5-min washes in PBS, the sections were incubated in 3% hydrogen peroxide in water for 10 min. After a further two 5-min washes in PBS, the sections were incubated in blocking buffer, consisting of 1.5% (vol/vol) normal horse serum (Vectastain kit; Vector Laboratories, Peterborough, UK) in PBS for 20 min and then blotted before incubation in a 1 µg/ml dilution of mouse anti-BMP-6 monoclonal antibody in PBS supplemented with 0.25% BSA (Sigma) overnight at 4 C. Negative controls were carried out by replacing the primary antibody with a 1:2352 dilution of mouse immunoglobulin (Sigma). Specificity was further confirmed by coincubating some slides with the primary antibody plus 2 µg/ml recombinant human (rh) BMP-6 overnight at 4 C. Following a further two 5-min washes in PBS, the sections were incubated in a 1:200 dilution of biotinylated horse antimouse immunoglobulin (Vectastain kit, Vector Laboratories) in blocking buffer for 20 min at room temperature. The sections were again washed twice in PBS for 10 min before incubation in the avidin-biotin peroxidase complex (Vectastain kit, Vector Laboratories) for 30 min at room temperature. After a final wash in PBS, bound antibodies were visualized as brown staining by a 5-min incubation in 3–3'diaminobenzidine (Vector Laboratories). The sections were counterstained with Mayer’s hematoxylin (NuStain, Nottingham, UK), dehydrated through increasing concentrations of alcohols and mounted using DPX mounting medium (NuStain) and coverslips. The slides were observed using a DMRB microscope (Leica, Wetzlar, Germany) for evidence of specific staining and assessed by two independent observers who classified staining in the theca, membrane granulose, and oocyte (if present) of primary/secondary (one to two layers of cuboidal granulosa cells), multilaminer preantral, small antral (<1 mm diameter), and antral follicles (1–6 mm diameter) on a scale of 1–6 with 1 being no staining, 2 being very light staining, 3 being light staining, 4 being medium staining, 5 being heavy staining, and 6 being very heavy staining. A minimum of 10 follicles per class were assessed in this way and the mean value from the two observers used for subsequent analysis.

Serum-free culture of granulosa and theca cells
The methodologies used for the collection and culture of sheep granulosa (36) and theca (37) cells have been previously described. Briefly, small (< 3.5 mm in diameter) ovarian follicles were dissected from ovaries collected from the abattoir in Medium 199 containing 20 mmol HEPES l–1, 100 kIU penicillin l–1, 0.1 µg streptomycin l–1, and 1 mg amphotericin (Fungizone) l–1 at 37 C with specific attention being given to the removal of all extraneous stromal tissue from the follicle wall. Small follicles were hemisected in Dulbecco’s PBS without calcium or magnesium and the follicle halves flushed repeatedly up and down the barrel of a 1-ml syringe. The thecal shells were allowed to settle, the granulosa cell rich supernatant removed, and the flushing procedure repeated. The antral fluid of large follicles was removed using a 1-ml syringe and 23G needle before the follicles were hemisected and granulosa cells removed by gentle scraping with an inoculation loop. The granulosa cell were washed twice in culture medium (McCoy’s 5a supplemented 100 kIU penicillin l–1, 0.1 µg streptomycin l–1, 3 mmol L-glutamine l–1, 0.1% BSA (wt/vol), 2.5 mg transferrin l–1, 4 µg selenium l–1, 10–7 mol androstenedione l–1, and 10 ng/ml bovine insulin) before plating at a density of 75,000 viable cells/well into preprepared and equilibrated 96-well plates containing 200 µl culture medium.

The thecal shells were dispersed in an enzyme mix containing 5 g collagenase l–1, 1 g hyaluronidase l–1, 1 g protease l–1, 2 g deoxyribonuclease l–1, and 0.002% donor calf serum (vol/vol) in 20 ml PBS for 30–45 min at 37 C with gentle agitation. The reaction was stopped by the addition of 2 ml donor calf serum and the cells washed twice in culture medium (DMEM-F12 with 100 kIU penicillin l–1, 0.1 µg streptomycin l–1, 3 mmol L-glutamine l–1, 0.1% BSA (w/vol), 2.5 mg transferrin l–1, 4 µg selenium l–1, 10 ng/ml bovine insulin, and 10 ng/ml LR3 IGF-I) before plating at a density of 75,000 viable cells/well (<1% contamination by granulosa cells) into preprepared and equilibrated 96-well plates containing 200 µl culture medium.

Cells were cultured in a humidified atmosphere with 5% carbon dioxide in air at 37 C. Granulosa and theca cells were cultured for a total of 8 and 6 d, respectively, with medium being changed at 48-h intervals. To minimize disturbance of the cells, only 175 µl media were gently removed and replaced at each change. The spent medium was stored at –20 C before assay. At the end of culture, the number of viable cells/well was estimated using neutral red uptake and the results expressed as nanograms of hormone produced per 10,000 viable cells per 48 h.

Experimental design
Effects of different BMPs and interaction with IGF-I and gonadotropins.
These experiments used tissue from wild-type animals obtained from the abbattoir to examine the dose-responsive effects of BMP-2, -4, and -6 on gonadotropin-induced granulosa and theca cell proliferation and differentiation and the interaction of these BMPs with the dose of FSH and IGF-I. Initial experiments tested the effect of BMP-6 (5 ng/ml) on the responsiveness and sensitivity of granulosa cells from small follicles to stimulation with FSH (0.001–10 ng/ml) and the interaction of BMP-6 with the differentiative factor IGF-I LR3 (1 ng/ml). Dose-response curves (0–50 ng/ml) for BMP-2, -4, and -6 were then established in granulosa and theca cells with a constant dose of gonadotropin previously shown to induce cellular differentiation (10 ng/ml oFSH-16 for granulosa and 0.1 ng/ml oLH-26 for theca) and a range of doses of IGF-I LR3 (0, 0.1, 1, and 10 ng/ml) previously shown to modulate somatic cell differentiation and proliferation (36, 37). Insulin concentrations were maintained at a dose of 10 ng/ml throughout. For these experiments, within cultures each dose combination was replicated in quadruplicate and each culture was repeated at least three times.

Effect of FecB mutation
These experiments examined the differential sensitivity of granulosa and theca cells from wild-type animals and ewes carrying the FecB mutation to FSH; LH; IGF-1 LR3; TGF{alpha}; and BMP-2, -4, and -6. A common observation in FecB carriers is a change in the follicular hierarchy, and thus, for the gonadotropin dose-response studies, follicles were divided into three size classes: small (1–2.5 mm diameter), medium (2.5–4.5 mm), and large (>4.5 mm diameter), and where sufficient cells were available dose responses were established for FSH (0–10 ng/ml oFSH) and LH (0–10 ng/ml oLH-26) at constant doses of IGF-I LR3 (10 ng/ml) and insulin (10 ng/ml). IGF-I LR3 dose responses (0–10 ng/ml) used optimum doses of insulin (10 ng/ml) and FSH (10 ng/ml), whereas TGF{alpha} dose responses used optimum doses of FSH (10 ng/ml), insulin (10 ng/ml), and IGF LR3 (10 ng/ml). For BMP dose-response studies, four doses (0, 1, 10, and 30 ng/ml) were used for each BMP with two doses of IGF-I LR3 (0.1 and 10 ng/ml), with a constant dose of gonadotropin (10 ng/ml oFSH and 0.1 ng/ml oLH-26) and insulin (10 ng/ml). Due to the rarity of these animals and the need to breed replacements, these cultures were performed as sufficient numbers become available from 1995 onward. In each year, six to eight ewes per line were killed to generate sufficient tissue for two replicate cultures established on successive days that compared the response of cells from the two lines with a particular factor. For these experiments, within cultures each dose combination was replicated at least in triplicate, and each culture was repeated at least twice with data being blocked by replicate culture for analysis.

Assays
Concentrations of estradiol (36), androstenedione (37), and inhibin A (41) in unextracted culture media were determined using previously described RIAs. For inhibin A measurements, culture media had to be diluted between 1:10 and 1:1000 in assay buffer. The sensitivity of the assays for estradiol, androstenedione, progesterone, and rh inhibin A were 50 pmol/liter, 175 pmol/liter, 380 pmol/liter, and 30 ng/liter, respectively. The intra- and intercoefficients of variation for all assays were less than 15%.

Statistical analysis
With the exception of the time-course data, all hormone production data were expressed as amount of hormone produced per 48 h per 10,000 cells (10 kcells). Because accurate cell number data were not available at 96 and 144 h of culture, the time-course data were expressed as a concentration. Following tests for normality and homogeneity, the significance of treatment effects was determined by ANOVA using replicate cultures as blocks, both within and across different years. Individual comparisons between treatments were made using Bonferroni’s test. For immunohistochemistry intensity scores, data were not normally distributed and was therefore analyzed by either Mann-Whitney U or Kruskal-Wallis H test, as was appropriate, using SPSS (Chicago, IL).


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
Characterization studies
Granulosa cells.
Experiments designed to test the effect of BMP on the responsiveness of granulosa cells from small follicles to FSH, revealed an additive effect of BMP and IGF-I on FSH-stimulated estradiol production (Fig. 1Go). Thus, addition of BMP-6 (5 ng/ml) or IGF-I (1 ng/ml) to granulosa cells cultured in the presence of insulin (10 ng/ml) resulted in identical FSH dose response curves, whereas combined addition of both factors resulted in a 2-fold increase in the response of the cells to effective doses of FSH (Fig. 1Go). It is also notable from this experiment that BMP-6 had no effect on the sensitivity of the granulosa cells to FSH with only doses of 1 and 10 ng/ml, resulting in a significant induction of aromatase activity as measured by estradiol production. As previously described (36), FSH in the presence of insulin alone induced a 70% (P < 0.01) increase in cell number with an ED50 of 0.01 ng/ml. BMP-6 alone had no effect on this dose response, whereas addition of IGF-I, with or without BMP-6, resulted in maximal cell numbers at all doses of FSH (data not shown).


Figure 1
View larger version (21K):
[in this window]
[in a new window]
  		FIG. 1. Mean ± SEM estradiol production by granulosa cells after 192 h culture with increasing doses of oFSH in the presence of 10 ng/ml insulin (full triangle); insulin and 5 ng/ml BMP-6 (open circle); insulin and 10 ng/ml IGF-I LR3 (closed circle); or insulin, BMP-6, and IGF-I LR3 combined (open squares). Column represents overall mean production in presence of all factors in the absence of FSH. Asterisks indicate significant difference from zero dose of FSH: *, P < 0.05; **, P < 0.01; and ***, P < 0.001. {dagger}, Significant difference between BMP and IGF supplementation alone, compared with combined treatment at a given dose of FSH with {dagger}{dagger}, P < 0.01.

 
In the presence of constant doses of FSH (10 ng/ml), all BMPs had a highly significant effect on estradiol production (Fig. 2Go; P < 0.001) and across all doses, exposure to BMP-4 (37.6 ± 2.5 pg per 48 h per 10 kcells) resulted in higher levels of estradiol production than either BMP-2 (28.5 ± 2.5 pg per 48 h per 10 kcells) or BMP-6 (24.6 ± 2.5 pg per 48 h per 10 kcells) at the end of culture. As previously shown (36), a dose of IGF-I had a highly significant effect on estradiol production (P < 0.001) and there was a significant interaction between dose of BMP and dose of IGF-I (P < 0.05). This interaction is illustrated in Fig. 2Go, which shows the characteristic flattening of the BMP dose response at higher doses of IGF-1. It is also notable that across all doses of IGF-I, the maximum stimulatory dose of BMP is 5 ng/ml (41.2 ± 2.9 pg per 48 h per 10 kcells), with the 50 ng/ml dose being inhibitory (29.6 ± 2.9 pg per 48 h per 10 kcells; P < 0.01). There were no significant interactions between type and dose of BMP or type of BMP and dose of IGF-I.


Figure 2
View larger version (22K):
[in this window]
[in a new window]
  		FIG. 2. Mean ± SEM estradiol production by granulosa cells after 192 h culture with increasing doses of BMP in the presence of 10 ng/ml insulin and FSH (open square); insulin, FSH, and 0.1 ng/ml IGF-1 LR3 (full diamond); insulin, FSH, and 1 ng/ml IGF-I LR3 (open circle); and insulin, FSH, and 10 ng/ml IGF-I LR3 (closed triangle). Estradiol production data from cultures using BMP-2, -4, and -6 have been pooled due to lack of affect of type of BMP (ANOVA). A marked interaction between dose of BMP and IGF-I is clearly evident from the data (P < 0.05), with a flattening of the BMP dose-response curve with increasing dose of IGF-I. Asterisks indicate significant difference from zero dose of BMP within each dose of LR3 IGF-I: *, P < 0.05; **, P < 0.01; and ***, P < 0.001.

 
In contrast, there was no significant effect of dose of BMP on granulosa cell number after 8 d of culture (P = 0.3), but across all doses (0.5–50 ng/ml), exposure to BMP-6 (141 ± 5 kcells) resulted in more (P < 0.01) cells at the end of culture than either BMP-2 (113 ± 5 kcells) or BMP-4 (125 ± 5 kcells). As previously shown (36), a dose of IGF-1 had a highly significant effect on cell number (P < 0.001), and there was a significant interaction between dose of IGF and type of BMP (P < 0.01), with BMP-6 (223 ± 10 kcells) resulting in higher cell numbers than BMP-4 (174 ± 10 kcells) or BMP-2 (151 ± 10 kcells) at the highest dose of IGF-I LR3 (10 ng/ml).

Theca cells.
In marked contrast to granulosa cells, all BMPs had a highly significant inhibitory effect on androstenedione production (Fig. 3AGo; P < 0.001) by theca cells. In this instance, however, there was a significant interaction between type and dose of BMP (P < 0.01), with BMP-6 being less potent than BMP-2 and -4 (Fig. 3AGo). There was no interaction between dose of IGF and type (P = 0.8) or dose of BMP (P = 0.7) for androstenedione production. In addition, low doses of BMPs stimulated a marked increase (P < 0.001) in theca cell number after 6 d of culture (Fig. 3BGo). There was no difference between types of BMP in the magnitude of this effect (P = 0.3). As previously shown (37), a dose of IGF-I had a highly significant effect on cell number (P < 0.001), but there was no interaction between dose of IGF and type (P = 0.8) or dose of BMP (P = 0.8). The combined effect of increased cell number and decreased production per cell resulted in an increase (P < 0.05) in total steroid production at the lowest doses of BMP-4 and -6 and a highly significant depression (P < 0.001) at the highest doses (Fig. 3CGo).


Figure 3
View larger version (29K):
[in this window]
[in a new window]
  		FIG. 3. BMP in thecal cells: effect of BMP-2 (open bars), BMP-4 (hatched bars), and BMP-6 (closed bars) on androstenedione production corrected for cell number (A), cell number (B), and total androstenedione production (C) by thecal cells after 144 h of culture. Stippled bar indicates production in the absence of any BMP and asterisks indicate significant difference from zero dose of BMP: *, P < 0.05, **, P < 0.01 and ***, P < 0.001. Values are mean ± SEM.

 
BMP-6 Protein expression
The potential physiological relevance of these effects of BMPs on the differentiation and proliferation of cultured sheep granulosa and theca cells was confirmed by immunohistochemical analysis showing abundant expression of at least one BMP, BMP-6, in the oocyte, granulosa cell, and theca cell layers at all stages of follicle development in sheep (Fig. 4Go and Table 1Go). Across all follicle classes, high-intensity staining was observed for BMP-6 in the oocyte and membrana granulosa cell layer with much fainter staining in the theca cell layer (Fig. 4Go, A–D, and Table 1Go). Within cell type, there was a significant increase in BMP-6 protein expression with increasing follicle size, but this effect was more marked for the theca and granulosa cells layers (P < 0.001) than for the oocyte (P < 0.02; Table 1Go). The specificity of this staining was confirmed by control slides (Fig. 4Go, E and F). When primary antibody was omitted, no staining was observed (Fig. 4FGo), whereas when the primary antibody was preabsorbed with BMP-6, the mean staining intensity in antral follicles was markedly reduced (P < 0.001) to values of 1.1, 2.0, and 2.5 for theca, granulose, and oocytes, respectively. In relation to the granulosa cells, much of this retained staining was restricted to the cells lining the antral cavity (Fig. 4EGo). Similar patterns of BMP-6 expression were observed in ovarian tissue from both wild-type and FecB/B carrier ewes (not shown).


Figure 4
View larger version (147K):
[in this window]
[in a new window]
  		FIG. 4. Representative images showing BMP-6 protein expression in the sheep ovary. Strong expression was observed in the oocyte, cumulus and membrana granulosa cell layer at all stages of follicle development, with examples shown in large antral (A), early antral (B), and primary/secondary (C) stages of development. Lower levels of expression were also observed in the theca interna, particularly in large antral follicles (A and D). Images D–F show sections from the same large antral follicle exposed to primary antibody, primary antibody plus 2 µg/ml BMP-6, and no primary antibody. Note the absence of staining in the absence of primary antibody (F) and the marked decline in staining, particularly in the basal membrana granulosa and theca interna in sections coincubated with BMP-6. Image magnifications: x100, x200, x400, x100, x100, and x100 for A, B, C, D, E, and F, respectively.

 

View this table:
[in this window]
[in a new window]
  		TABLE 1. Mean and range (in parentheses) staining intensity for BMP-6 in the somatic cells and oocytes of ovine follicles from wild-type animals at different stages of development determined by immunohistochemistry and semiquantified by two independent observers using subjective criteria

 
FecB culture studies
Follicle populations and ovulation rates.
Ovarian tissue from FecB/B ewes exhibited the characteristic increase in ovulation rate (4.7 ± 0.7 FecB/B vs. 1.7 ± 0.3 Fec+/+; P < 0.01) and decrease in corpus luteum weight (0.26 ± 0.01 g FecB/B vs. 0.64 ± 0.08 g Fec+/+; P < 0.01). Similarly, the follicle population between genotypes differed markedly with no large follicles greater than 4.5 mm in diameter being obtained from FecB/B animals (n = 32), compared with an average of 2.2 ± 0.6 from each Fec+/+ ewe (n = 30). The number of medium-sized (2.5–4.5 mm) follicles did not differ between genotypes (6.4 ± 2.2 Fec+/+ vs. 7.4 ± 1.7 FecB/B/ewe), but there was a tendency for more (P = 0.08) small-sized (1–2.5 mm) follicles in FecB/B (54.4 ± 8.0/ewe) than Fec+/+ (34.6 ± 5.7/ewe) ewes. Furthermore, follicles recovered from FecB/B animals within this size category tended to be smaller than follicles from Fec+/+ ewes. Across all cultures, there were insufficient data from cultures using cells from medium-sized follicles to make valid comparisons between genotypes, and therefore, only data from the small follicle category are presented.

Gonadotropin and growth factor responses.
There was no difference between genotypes in steroid production by granulosa or theca cells from small follicles during the initial 48 h of culture, but in cells exposed to the optimum doses of gonadotropins, insulin, and IGF-I LR3 known to induce cellular differentiation (36, 37), induction profiles differed between genotypes with higher levels of production by somatic cells from FecB/B animals from 96 h of culture onward (Fig. 5).

Granulosa cells from both genotypes responded to stimulation by FSH in a dose-responsive manner (P < 0.001), with cells from FecB/B ewes exhibiting a significantly greater response at doses greater than 1 ng/ml (Fig. 6AGo; P < 0.01). Granulosa cells from neither genotype responded to stimulation with LH, although estradiol production levels were higher (P < 0.05) in cells from FecB/B across the dose range (Fig. 6BGo). There was no difference between genotypes in proliferative responses of either granulosa or theca cells (data not shown) to either FSH or LH. Granulosa cells from both genotypes cultured in the presence of optimum doses of FSH, insulin, and IGF-I exhibited similar responses to the mitogenic growth factor TGF{alpha}, with a marked depression in estradiol production (Fig. 6CGo; P < 0.001) and a concomitant 44–56% increase in cell number (P < 0.01), resulting in no significant interaction between genotype and dose of TGF{alpha} for either of these parameters. However, there was a significant (P < 0.05) effect of genotype on estradiol production due to the higher levels of production by cells from FecB/B animals at the zero dose (Fig. 6CGo). A converse dose response was obtained when cells were exposed to the differentiative factor IGF-I, in the presence of 10 ng/ml insulin and 10 ng/ml FSH, with a marked stimulation in estradiol production in both genotypes (P < 0.001). In this instance, however, there was a highly significant effect of genotype (P < 0.001) and a significant interaction (P < 0.01), with cells from FecB/B follicles exhibiting a greater response to doses greater than 1 ng IGF-I LR3/ml (Fig. 6DGo). There was no difference between genotypes in the proliferative response of granulosa cells to IGF-I (data not shown).


Figure 6
View larger version (27K):
[in this window]
[in a new window]
  		FIG. 6. Effect of FecB mutation on response of granulosa cells to gonadotropins and other growth factors. These data show estradiol production by granulosa cells isolated from small antral follicles of Fec+/+ (open column) and FecBF/F (closed column) animals and cultured under serum-free conditions in the presence of increasing doses of FSH (A), LH (B), TGF{alpha} (C), and IGF LR3 (D). FSH and LH doses responses were conducted with 10 ng/ml insulin and IGF-I. TGF{alpha} dose responses were conducted with 10 ng/ml FSH, insulin, and IGF-I. IGF dose responses were conducted with 10 ng/ml insulin and FSH. Values are mean ± SEM, and asterisks denote significant difference between genotypes at the same dose: *, P < 0.05, **, P < 0.01, and ***, P < 0.001. Note that the data have been corrected for cell number.

 
Theca cells from both genotypes responded to stimulation by LH in a characteristic (37) bimodal dose responsive manner (P < 0.001), with cells from FecB/B ewes exhibiting a significantly greater response at the nonluteinizing doses of 0.01 and 0.1 ng LH per milliliter (Fig. 7AGo; P < 0.01). Theca cells from both genotypes cultured in the presence of optimum doses of LH, insulin, and IGF-I exhibited similar responses to the mitogenic growth factor TGF{alpha}, with a marked dose-responsive depression in androstenedione production (Fig. 7BGo; P < 0.001). There was a significant (P < 0.05) effect of genotype on androstenedione production due to the higher levels of production by cells from FecB/B animals at the zero dose. As with the granulosa cells, a converse dose response was obtained when cells were exposed to the differentiative factor IGF-I LR3, in the presence of 10 ng/ml insulin and 0.1 ng/ml LH, with a marked stimulation in androstenedione production in both genotypes (P < 0.001). Furthermore, there was a highly significant effect of genotype (P < 0.001) but no interaction (P = 0.2), with cells from FecB/B follicles exhibiting a greater androstenedione response to doses greater than 1 ng IGF-I LR3 per milliliter when compared with cells from Fec+/+ animals (Fig. 7CGo). There was no difference between genotypes in the proliferative response of theca cells to either TGF{alpha} or IGF-I (data not shown).


Figure 7
View larger version (13K):
[in this window]
[in a new window]
  		FIG. 7. Effect of FecB mutation on response of theca cells to gonadotropins and other growth factors. These data show androstenedione production by theca cells isolated from small antral follicles of Fec+/+ (open column) and FecBF/F (closed column) animals and cultured under serum-free conditions in the presence of increasing doses of LH (A), TGF{alpha} (B), and IGF LR3 (C). LH doses responses were conducted with 10 ng/ml insulin and IGF-I. TGF{alpha} dose responses were conducted with 0.1 ng/ml LH and 10 ng/ml insulin and IGF-I. IGF dose responses were conducted with 0.1 ng/ml LH and 10 ng/ml insulin. Values are mean ± SEM, and asterisks denote significant difference between genotypes at the same dose: *, P < 0.05, **, P < 0.01; and ***, P < 0.001. Note that the data have been corrected for cell number.

 
BMP dose responses.
As previously observed in the studies using wild-type material from the abattoir, there were no significant differences among BMP-2, -4, and -6 in terms of their ability to stimulate estradiol production by granulosa cells, and these data have therefore been pooled within genotype for analysis. Over all doses of IGF-I LR3 and BMP, granulosa cells from FecB/B animals produced significantly more estradiol and inhibin A (P < 0.001) than cells from wild-type animals, but the sensitivity of the cells to BMP stimulation depended on the dose of IGF-I LR3 included in the culture (Fig. 8Go). Thus, at a dose of 0.1 ng IGF-I LR3 per milliliter, dose of BMP had a highly significant effect on both estradiol (P < 0.001) and inhibin A (P < 0.01) production by cells from FecB/B ewes, whereas cells from Fec+/+ animals were relatively refractory to BMP under these conditions. Thus, there were significant differences in estradiol production between genotypes at all doses of BMP when IGF-I was low but no difference in the absence of BMP (Fig. 8Go, A and B). Conversely, at a dose of 10 ng/ml IGF-I LR3 per milliliter, estradiol responses to BMP were not observed (P = 0.06), with a highly significant difference between genotypes (P < 0.001) being maintained across all doses of BMP (interaction P = 0.9: Fig. 8CGo). A similar response was observed in terms of inhibin A, although analysis did show a statistically significant effect of dose of BMP on inhibin A production (P < 0.01; Fig. 8DGo). There was no significant effect of dose of BMP on granulosa cell number in either genotype at the end of culture in this experiment.


Figure 8
View larger version (33K):
[in this window]
[in a new window]
  		FIG. 8. Effect of FecB mutation on response of granulosa cells to BMPs. These data show estradiol (A and C) and inhibin A (B and D) production by granulosa cells isolated from small antral follicles of Fec+/+ (open column) and FecBF/F (closed column) animals and cultured under serum-free conditions for 192 h in the presence of increasing doses of BMP. Because there was no significant difference among BMP-2, -4, and -6, data have been pooled within genotype. All dose responses were conducted in the presence of 10 ng/ml FSH and either 0.1 ng/ml (A and B) or 10 ng/ml (C and D) IGF-I LR3. Values are mean ± SEM, and asterisks denote significant difference between genotypes at the same dose: *, P < 0.05, **, P < 0.01, and ***, P < 0.001. Note that the data have been corrected for cell number.

 
Because characterization studies had shown differential sensitivity of theca cells to different BMPs, these studies were conducted using just BMP-6, which we have shown is expressed in sheep thecal tissue in vivo (see above) and used a dose range of 0.005–50 ng/ml. Marked differences were observed between genotypes in terms of cell number and steroid production in response to exposure to different doses of BMP-6 (Fig. 9Go). There was a significant dose-dependant increase in theca cell number and a decrease in androstendione production in response to BMP6 in cells from the wild type. In marked contrast, theca cells from FecB/B ewes did not exhibit this proliferative response, with the result that there was a highly significant difference between genotypes (P < 0.001) and a highly significant interaction between genotype and dose of BMP (Fig. 9AGo). In addition, androstenedione production by theca cells from FecB/B ewes was markedly increased in response to lower doses of BMP-6, whereas an inhibitory effect was observed in cells from wild-type animals (Fig. 9BGo). This resulted in significant differences in androstenedione production between genotypes for doses between 0.005 and 0.5 ng BMP-6 per milliliter and a significant (P < 0.01) interaction between genotype and dose of BMP-6.


Figure 9
View larger version (21K):
[in this window]
[in a new window]
  		FIG. 9. Effect of FecB mutation on response of theca cells to BMPs. These data show cell number (A) and androstenedione production (B) by theca cells isolated from small antral follicles of Fec+/+ (open column) and FecBF/F (closed column) animals and cultured under serum-free conditions for 144 h in the presence of increasing doses of BMP-6. The dose responses were conducted in the presence of 0.1 ng/ml FSH, 10 ng/ml insulin, and IGF-I LR3. Values are mean ± SEM, and asterisks denote significant difference between genotypes at the same dose: *, P < 0.05, **, P < 0.01, and ***, P < 0.001. Note that the androstenedione production data have been corrected for cell number and that the cell number data have been presented as a percentage relative to cell number at the zero dose of BMP-6.

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
The results of the present studies are consistent with a major role for the BMP system in a monovulatory species in modulating proliferative and differentiative responses of ovarian somatic cells to gonadotrophic stimulation and indicate a significant interaction of BMPs with other key local regulatory systems. Initial characterization studies with granulosa cells confirmed and extended our previous observations in sheep (22) showing that BMP-2, -4, and -6 were equally potent in augmenting FSH-stimulated estradiol production and revealed a marked interaction between BMPs and the level of IGF stimulation. Parallel studies in theca cells showed for the first time that BMPs inhibit cellular differentiation at higher doses but stimulate cellular proliferation at lower doses that were ineffective in granulosa cells. The potential physiological significance of these observations was confirmed by immunohistochemical analysis showing expression of BMP-6 in sheep ovarian somatic cells in vivo. Finally, culture studies using ovarian tissue from ewes with the FecB mutation showed that the mutation resulted in an increased differentiative response of both granulosa and theca cells to BMP, gonadotropin, and IGF-I stimulation. The increased responsiveness of ovarian somatic cells to these factors could account for the precocious maturation of antral follicles in FecB mutants, which is characterized by the development of aromatase activity and LH receptors by granulosa cells of antral follicles at markedly smaller diameters than in wild-type ewes (30, 31, 32). Furthermore, because these preovulatory follicles are much smaller, the total amount of ovarian estradiol secreted by FecB mutants does not differ from wild-type animals (41), with the consequence that the number of follicles capable of ovulating in response to the LH surge is markedly increased in FecB mutants. These in vitro observations are therefore consistent with the profound effect of the FecB mutation in inducing precocious maturation of ovarian follicles and hence deregulating the normal follicle selection mechanisms operating in this species.

The existence of an interaction between level of gonadotropin stimulation and dose of BMP and IGF in determining level of estradiol secretion by granulosa cells was a major finding of the initial characterization studies. The results presented in Fig. 1Go illustrate that, like IGF-I, BMP-6 acts by augmenting FSH-stimulated differentiation because neither IGF-I nor BMP-6 alone is capable of stimulating estradiol secretion under these conditions. Furthermore, the fact that coaddition of low doses of BMP-6 and IGF-I induce an additive augmentation of FSH-stimulated estradiol secretion suggests that each of these stimulatory systems are acting through their separate signaling cascades to influence a common end point, namely the induction of aromatase activity. It is also clear from Fig. 1Go that neither BMP-6 nor IGF-I had any effect on the sensitivity of the granulosa cells to FSH stimulation, in which case a shift in the dose-response curve to the left would have been expected. Additional studies with BMP-2 and -4 have also failed to demonstrate any change in granulosa cell sensitivity to FSH (Campbell, B. K., unpublished observations). It is therefore unlikely that BMPs are exerting their effects in sheep through modulating FSH receptor number (13), although this possibility requires more direct experimental evaluation. Finally, the lack of effect of BMP-6 on FSH-stimulated proliferation suggests that unlike IGF-I and insulin (36), BMP-6 does not modulate both proliferation and differentiation in this species.

The results presented in Fig. 2Go, in which FSH was held constant and dose of BMP and IGF altered across a range of effective doses for local factors, confirm the interactive effect among BMPs (2, 4, and 6) and IGF-I in stimulating induction of estradiol production. The similar nature of the estrogenic responses obtained for BMP-2, -4, and -6 suggests that each of these factors is acting via a common receptor and signaling cascade in ovine granulosa cells. This finding contrasts with that observed in rodents (12) but agrees with the findings of a comparable study in the bovine in which no difference was found among BMP-4, -6, and -7 in terms of their ability to induce secretion of differentiative markers (21). These authors also found that doses of BMP in the range of 2–50 ng/ml were effective and that the magnitude of the response obtained was affected by the dose of IGF-I. However, these results are not directly comparable with those reported in the current paper because these bovine cultures were apparently performed in the absence of FSH (21).

In marked contrast to responses observed in granulosa cells, doses of BMP-2, -4, and -6 greater than 0.5 ng/ml inhibited LH-stimulated thecal androstenedione production, whereas very low doses, ineffective in granulosa cells, stimulated an increase in thecal cell number. Furthermore, there was a difference between BMPs in that BMP-6 was a less potent inhibitor of androstenedione production than BMP-2 and -4 (Fig. 3Go). The most likely explanation for these apparently contradictory responses of ovarian somatic cells to BMP stimulation is suggested by the results of immunohistochemical analysis of BMP-6 expression in sheep ovary (Fig. 4Go), in which intense staining is seen in the granulosa cell layer with much fainter, but definite, staining for BMP-6 in the theca cell layer. It is therefore likely that theca cells may be exposed to very low levels of BMP in vivo and that the higher doses observed to be inhibitory in vitro are in fact superphysiological for this cell type. In this case, the observed proliferative response to very low levels of BMP would be consistent with a role for BMP in increasing the steroidogenic potential of a follicle by increasing the number of steroidogenic thecal cells. This interpretation is supported by the fact that total androgen production is increased at low doses of BMP, due to the increase in cell number (Fig. 3CGo). Thus, we would hypothesize that during the growth and maturation of ovarian follicles, as they move into the gonadotropin-dependent phase (8), higher levels of exposure of granulosa cells to BMP would augment FSH-stimulated estradiol production, whereas lower levels of exposure of theca cells to BMP would in turn increase LH-stimulated androgen precursor supply for estrogen production. The potent inhibitory effect of BMPs on thecal androstenedione production has recently been confirmed by data from the cow using a similar serum-free culture system (42). However, in the cow the BMPs seem to be acting as a more classical local factor in which proliferative and differentiative effects were inversely related, so that proliferative effects were observed only at higher doses of BMP greater than 1 ng/ml. Further work is required to determine whether this difference is due to species or methodological effects.

The demonstration that BMPs are expressed in vivo by sheep ovarian somatic cells was essential if we were to conclude that the responses obtained to these factors in vitro had physiological relevance. The results presented in Fig. 4Go support data from other species (15) in showing that BMP-6 is expressed by the sheep oocyte and therefore, like GDF-9 and BMP-15, may be secreted by the oocyte to modulate somatic cell function (43). Unlike reports from rodents (15) and isolated bovine somatic cells (21), we observed very intense staining for BMP-6 in the membrana-granulosa and less intense staining within the theca cell layer of most growing preantral and antral follicles in sheep. The specificity of this BMP-6 protein expression was confirmed by the marked reduction in the intensity of staining in the basal membrana granulosa and thecal cell layer in sections that had been coincubated with rhBMP-6. The staining that remained on the granulosa cells lining the antral cavity may have been nonspecific or due to high local concentrations of endogenous protein in the follicular fluid and around these cells. Similar expression patterns for BMP-6 have also been observed with fixed ovarian tissue from calves and cows and the specificity of this antibody for BMP-6 confirmed (44). Whereas these results support a physiological role for at least one of the BMPs tested in this work in modulating granulosa and theca cell function (see above), analysis of mRNA expression by in situ hybridization is required to confirm the source of the protein expression observed. Although it is likely that the oocyte is a source of BMP-6 expression within the sheep follicle, the high level and widespread distribution of BMP-6 protein expression within the granulosa cell layer of sheep antral follicles suggests that the granulosa cell layer may also secrete this factor in vivo. Conversely, the low level of BMP-6 expression in the theca cell layer of sheep antral follicles is consistent with the idea that for these cells this protein is acting as a paracrine factor derived from the oocyte and/or granulosa cell layer. However, Glister et al. (21) reported BMP-4 and -7 protein expression in isolated bovine theca cells and the confirmation of this hypothesis must await further analysis by in situ hybridization. As part of these expression studies, attempts were also made to examine the pattern of expression of BMP-2 and -4 protein in the ruminant ovary, but in our hands the commercial antibodies currently available for these proteins produced equivocal results (Dugan, K. and R. Webb, unpublished results). The demonstration, however, by Northern analysis that sheep ovary express mRNA for BMP-2, -4, -6, and -7 (3) strongly suggests that these factors also play a physiological role in the controlling ovarian function in these species. More systematic studies are therefore required to examine the effect of stage of follicle maturity and health on the pattern of mRNA and protein expression for components of the BMP system in monovulatory species.

The results of the culture studies on ovarian somatic cells from wild-type and carrier ewes of the FecB mutation confirm the results obtained from the BMP characterization studies and reveal a profound effect of the FecB mutation on both granulosa and thecal cell responsiveness to gonadotropin, IGF, and BMP stimulation in vitro. Induction profiles for estradiol and androstenedione production by granulosa and theca cells, respectively (Fig. 5Go), showed that the cells did not differ in their steroidogenic potential during the initial periods of culture but that under the influence of optimum doses of gonadotropin and IGF-I, induction profiles diverged so that cells from FecB animals produced two to three times more steroid at the end of culture on a per-cell basis than cells from wild-type animals. Examination of the gonadotropin and IGF-I dose responses (Figs. 6Go and 7Go) in these two cell types revealed that these genotypic differences were evident only at combined FSH/LH and IGF-I doses shown previously to induce steroid production (36, 37), revealing a clear interaction between these two differentiative factors in revealing the action of the mutation in vitro. Similarly, the more recent studies examining the effect of the mutation of BMP responses of granulosa cells (Fig. 8Go) showed that whereas the genotype effect is evident at maximal doses of IGF-I (10 ng/ml), suboptimal doses of IGF-I (0.1 ng/ml IGF-I) are required to reveal a marked increase in the sensitivity of granulosa cells from FecB mutants to BMP stimulation, in terms of both estradiol and inhibin A production.


Figure 5
View larger version (13K):
[in this window]
[in a new window]
  		FIG. 5. Time course of estradiol (top) and androstenedione (bottom) production by granulosa and theca cells, respectively, isolated from small antral follicles of Fec+/+ (closed circles) and FecBF/F (open circles) animals and cultured under serum-free conditions. Granulosa cells were cultured in the presence of 10 ng/ml oFSH, 10 ng/ml insulin, and 10 ng/ml IGF LR3 and theca cells in the presence of 0.1 ng/ml oLH, 10 ng/ml insulin, and 10 ng/ml IGF LR3. Note that levels of production do not differ between genotypes during initial periods of culture and then diverge as the cells differentiate. Values are mean ± SEM, and asterisks denote significant difference from the 48-h time point: **, P < 0.01; ***, P < 0.001.

 
As with the characterization studies, there were no differences among BMP-2, -4, and -6 within genotypes in terms of differentiative responses of granulosa cells, supporting the conclusion that these different BMPs are acting through common pathways in this cell type and suggesting that the effect of the FecB mutation is not ligand specific. This conclusion is consistent with the fact that the mutation occurs in the intracellular signaling region of the BMPR-1B (4). These results, however, contrast with those reported by French workers (6, 45) who reported that GDF-5 and BMP-4 inhibited progesterone secretion by cultured granulosa and that granulosa cells from FecB animals were less responsive than wild-type cells to GDF-5 and BMP-4. These results, however, are not directly comparable with those presented in this paper because the authors used markedly different culture conditions and did not report estradiol or inhibin A production, which are unequivocal markers of granulosa cell differentiation in ruminants (9, 10, 46, 47). Progesterone, on the other hand, cannot be regarded as an unequivocal marker of somatic cell differentiation in sheep because its increased production is not clearly associated with the transition from the gonadotropin-responsive to the gonadotropin-dependent stages in vivo (48), and increased production in vitro may also indicate some degree of unphysiological cellular transformation due to the propensity for cultured ruminant granulosa cells to undergo spontaneous luteinization (36). Accordingly, progesterone production has not been reported in the present paper, although, as with the rodent (13) and bovine (21, 42), we also observed that BMPs concomitantly stimulate estradiol production while inhibiting progesterone production by sheep granulosa cells (49).

Whereas differences between genotypes in responses of granulosa cells to stimulation with BMPs, even more profound effects were found in the response of the theca cells. These studies were restricted to the known physiological ligand BMP-6, and the results show a complete reversal to the responses observed in cells from wild-type animals (Figs. 3Go and 9Go), with no proliferative response and a marked augmentation of LH-stimulated androgen production at doses less than 0.5 ng/ml (Fig. 9Go).

Overall, the results of these culture studies show an increased differentiative response of both granulosa and theca cells to BMP, gonadotropin, and IGF-I stimulation ovarian tissue from FecB animals. Because the FecB mutation is known to be in the intracellular signaling region of the BMPR-1B, then the most likely explanation for the effects observed is that they occur as a consequence of the mutation causing an increased responsiveness of somatic cells to gonadotrophic stimulation through the interactions between BMPs and IGF-I observed in the present paper. The work of Fabre et al. (45), in which wild-type and FecB (Q249R) mutant BMPR-1B were transfected into human kidney cells, both supports and contradicts this hypothesis in that the FecB transfected cells exhibited an increase in basal luciferase activity (relative to the wild type) but failed to respond to stimulation with BMP-4. This latter result is, however, at odds with the findings of cell culture experiments in the same paper and also in the work reported here (Figs. 8Go and 9Go), showing that cells from FecB mutants do respond to BMP-4 and other members of the BMP family in vitro. Because differences in the cellular responsiveness of somatic cells from wild-type and FecB mutants persist in vitro under conditions in which exogenous BMPs are not added, for this hypothesis to be correct, endogenous sources of BMPs or other natural ligands must be present within the cultured cells. From the results of immunohistochemical analysis of ovarian BMP protein expression in ruminants presented in this and other papers (21), this appears to be very likely.

The alternative explanation for the increased responsiveness of somatic cells from FecB mutants to differentiative factors is that, although the cells came from the same size class, the effect of the mutation in inducing precocious follicular maturation meant that the cells were at a different stage of differentiation at the time of isolation. Two pieces of evidence argue against this interpretation. First, although from the same small follicle size class, changes in the follicular hierarchy caused by FecB mutation means that the majority of small follicles dissected from FecB animals were around 1 mm in diameter, whereas the majority of follicles dissected from wild-type animals were around 2 mm in diameter. The most likely explanation for this difference is that the cut-off for the transition from gonadotropin-responsive to gonadotropin-dependent status (8, 50) is altered by the mutation so that the pool of recruitable follicles tends to accumulate at a smaller diameter in FecB mutants. If this interpretation is correct, then we are comparing cells from follicles at a similar differentiative state, and this idea is supported by the fact that the time-course data show no difference in steroidogenic output during the initial periods of culture with similar induction profiles, with the main effect of the mutation being that it allowed cells to respond to differentiative stimuli to achieve a higher maximum level of steroid and inhibin A production. Second, we have shown that dispersion of ovarian somatic cells before culture results in a rapid loss in the mRNA expression of most differentiative markers, including FSH receptor, LH receptor, and aromatase, during the initial 24 h of culture, followed by a rapid sequential mRNA induction phase that precedes the induction of cellular steroidogenic activity (51). Thus, even if the somatic cells were at a more advanced differentiative stage at the time of collection, it is extremely likely that these disruptive effects would have reduced the cells to a common differentiative baseline during the initial period of culture.

In conclusion, the results of the present studies are consistent with a major role for the BMP system in a monovulatory species in modulating proliferative and differentiative responses of both granulosa and theca cells to gonadotrophic stimulation and indicate a significant interaction of BMPs with the IGF system. Culture studies using ovarian tissue from ewes with the FecB mutation showed that the mutation resulted in an increased differentiative response of both granulosa and theca cells to BMP, gonadotropin, and IGF-I stimulation, thus explaining the profound effect of the FecB mutation in inducing precocious maturation of ovarian follicles and hence deregulating the normal follicle selection mechanisms operating in this species.


   Acknowledgments
 
We gratefully acknowledge the technical assistance of Mrs. Catherine Pincott-Allen, Mr. Neil Hollow, and Mrs. Joan Docherty. We thank the National Institute of Arthritis, Metabolism, and Digestive Diseases for the ovine gonadotropins and inhibin, Professor B. Cooke for the androstenedione assay reagents. and Professor N. Groome for the inhibin A assay reagents.


   Footnotes
 
This work was supported by Biotechnology and Biological Science Research Council Research Grant 42/S20230 and European Union Grant CT 92-0232.

The authors have no conflict of interest.

First Published Online January 5, 2006

Abbreviations: BMP, Bone morphogenic protein; BMPR, BMP receptor; Fec+/+, animals without FecB mutation; GDF, growth differentiation factor; kcells, 1000 cells; o, ovine; rh, recombinant human.

Received May 18, 2005.

Accepted for publication December 22, 2005.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Bindon B 1984 Reproductive biology of the Booroola Merino sheep. Aust J Biol Sci 37:163–189[Medline]
  2. McNatty KP, Moore LG, Hudson NL, Quirke LD, Lawrence SB, Reader K, Hanrahan JP, Smith P, Groome NP, Laitinen M, Ritvos O, Juengel JL 2004 The oocyte and its role in regulating ovulation rate: a new paradigm in reproductive biology. Reproduction 128:379–386[Abstract/Free Full Text]
  3. Souza CJ, Campbell BK, McNeilly AS, Baird DT 2003 Bone morphogenetic proteins and folliculogenesis: lessons from the Booroola mutation. Reprod Suppl 61:361–370[Medline]
  4. Souza C, MacDougall C, Campbell B, McNeilly A, Baird D 2001 The Booroola (FecB) phenotype is associated with a mutation in the bone morphogenetic receptor type 1 B (BMPR1B) gene. J Endocrinol 169:R1–R6
  5. Wilson T, Wu X, Juengel J, Ross IK, Lumsden JM, Lord EA, Dodds KG, Walling GA, McEwan JC, O’Connell AR, McNatty KP, Montgomery GW 2001 Highly prolific Booroola sheep have a mutation in the intracellular kinase domain of bone morphogenetic protein IB receptor (ALK-6) that is expressed in both oocytes and granulosa cells. Biol Reprod 64:1225–1235[Abstract/Free Full Text]
  6. Mulsant P, Lecerf F, Fabre S, Schibler L, Monget P, Lanneluc I, Pisselet C, Riquet J, Monniaux D, Callebaut I, Cribiu E, Thimonier J, Teyssier J, Bodin L, Cognie Y, Chitour N, Elsen JM 2001 Mutation in bone morphogenetic protein receptor-IB is associated with increased ovulation rate in Booroola Merino ewes. Proc Natl Acad Sci USA 98:5104–5109[Abstract/Free Full Text]
  7. Souza CJ, Gonzalez-Bulnes A, Campbell BK, McNeilly AS, Baird DT 2004 Mechanisms of action of the principal prolific genes and their application to sheep production. Reprod Fertil Dev 16:395–401[Medline]
  8. Scaramuzzi R, Adams NR, Baird DT, Campbell BK, Downing JA, Findlay JK, Henderson KM, Martin GB, McNatty KP, McNeilly AS, Tsonis CG 1993 A model for follicle selection and the determination of ovulation rate in the ewe. Reprod Fertil Dev 5:459–478[CrossRef][Medline]
  9. Campbell B, Scaramuzzi R, Webb R 1995 Control of antral follicle development and selection in sheep and cattle. J Reprod Fertil Suppl 49:335–350[Medline]
  10. Campbell BK, Souza C, Gong J, Webb R, Kendall N, Marsters P, Robinson G, Mitchell A, Telfer EE, Baird DT 2003 Domestic ruminants as models for the elucidation of the mechanisms controlling ovarian follicle development in humans. Reprod Suppl 61:429–443[Medline]
  11. Webb R, Nicholas B, Gong JG, Campbell BK, Gutierrez CG, Garverick HA, Armstrong DG 2003 Mechanisms regulating follicular development and selection of the dominant follicle. Reprod Suppl 61:71–90[Medline]
  12. Shimasaki S, Moore RK, Erickson GF, Otsuka F 2003 The role of bone morphogenetic proteins in ovarian function. Reprod Suppl 61:323–337[Medline]
  13. Shimasaki S, Moore RK, Otsuka F, Erickson GF 2004 The bone morphogenetic protein system in mammalian reproduction. Endocr Rev 25:72–101[Abstract/Free Full Text]
  14. Shimasaki S, Zachow RJ, Li D, Kim H, Iemura S, Ueno N, Sampath K, Chang RJ, Erickson GF 1999 A functional bone morphogenetic protein system in the ovary. Proc Natl Acad Sci USA 96:7282–7287[Abstract/Free Full Text]
  15. Elvin JA, Yan C, Matzuk MM 2000 Oocyte-expressed TGF-ß superfamily members in female fertility. Mol Cell Endocrinol 159:1–5[CrossRef][Medline]
  16. Dube JL, Wang P, Elvin J, Lyons KM, Celeste AJ, Matzuk MM 1998 The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes. Mol Endocrinol 12:1809–1817[Abstract/Free Full Text]
  17. Aaltonen J, Laitinen MP, Vuojolainen K, Jaatinen R, Horelli-Kuitunen N, Seppa L, Louhio H, Tuuri T, Sjoberg J, Butzow R, Hovata O, Dale L, Ritvos O 1999 Human growth differentiation factor 9 (GDF-9) and its novel homolog GDF-9B are expressed in oocytes during early folliculogenesis. J Clin Endocrinol Metab 84:2744–2750[Abstract/Free Full Text]
  18. Otsuka F, Yao Z, Lee T, Yamamoto S, Erickson GF, Shimasaki S 2000 Bone morphogenetic protein-15. Identification of target cells and biological functions. J Biol Chem 275:39523–39528[Abstract/Free Full Text]
  19. Juengel JL, Hudson NL, Heath DA, Smith P, Reader KL, Lawrence SB, O’Connell AR, Laitinen MP, Cranfield M, Groome NP, Ritvos O, McNatty KP 2002 Growth differentiation factor 9 and bone morphogenetic protein 15 are essential for ovarian follicular development in sheep. Biol Reprod 67:1777–1789[Abstract/Free Full Text]
  20. Hino J, Takao M, Takeshita N, Konno Y, Nishizawa T, Matsuo H, Kangawa K 1996 cDNA cloning and genomic structure of human bone morphogenetic protein-3B (BMP-3b). Biochem Biophys Res Commun 223:304–310[CrossRef][Medline]
  21. Glister C, Kemp CF, Knight PG 2004 Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin. Reproduction 127:239–254[Abstract/Free Full Text]
  22. Souza C, Campbell B, McNeilly A, Baird D 2002 The effect of bone morphogenetic protein (BMP) 2 on oestradiol and inhibin A production by sheep granulosa cells and localisation of BMP receptors in the ovary by immunohistochemistry. Reproduction 123:363–369[Abstract]
  23. Otsuka F, Moore RK, Shimasaki S 2001 Biological function and cellular mechanism of bone morphogenetic protein-6 in the ovary. J Biol Chem 276:32889–32895[Abstract/Free Full Text]
  24. Otsuka F, Yamamoto S, Erickson GF, Shimasaki S 2001 Bone morphogenetic protein-15 inhibits follicle-stimulating hormone (FSH) action by suppressing FSH receptor expression. J Biol Chem 276:11387–11392[Abstract/Free Full Text]
  25. Vitt UA, Hayashi M, Klein C, Hsueh AJ 2000 Growth differentiation factor-9 stimulates proliferation but suppresses the follicle-stimulating hormone-induced differentiation of cultured granulosa cells from small antral and preovulatory rat follicles. Biol Reprod 62:370–377[Abstract/Free Full Text]
  26. Galloway SM, McNatty KP, Cambridge LM, Laitinen MP, Juengel JL, Jokiranta TS, McLaren RJ, Luiro K, Dodds KG, Montgomery GW, Beattie AE, Davis GH, Ritvos O 2000 Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat Genet 25:279–283[CrossRef][Medline]
  27. Davis GH, Dodds KG, Wheeler R, Jay NP 2001 Evidence that an imprinted gene on the X chromosome increases ovulation rate in sheep. Biol Reprod 64:216–221[Abstract/Free Full Text]
  28. Hanrahan JP, Gregan SM, Mulsant P, Mullen M, Davis GH, Powell R, Galloway SM 2004 Mutations in the genes for oocyte-derived growth factors GDF9 and BMP15 are associated with both increased ovulation rate and sterility in Cambridge and Belclare sheep (Ovis aries). Biol Reprod 70:900–909[Abstract/Free Full Text]
  29. Davis GH, Galloway SM, Ross IK, Gregan SM, Ward J, Nimbkar BV, Ghalsasi PM, Nimbkar C, Gray GD, Subandriyo, Inounu I, Tiesnamurti B, Martyniuk E, Eythorsdottir E, Mulsant P, Lecerf F, Hanrahan JP, Bradford GE, Wilson T 2002 DNA tests in prolific sheep from eight countries provide new evidence on origin of the Booroola (FecB) mutation. Biol Reprod 66:1869–1874[Abstract/Free Full Text]
  30. McNatty K, Henderson K, Lun S, Heath DA, Ball K, Hudson NL, Fannin J, Gibb M, Kieboom LE, Smith P 1985 Ovarian activity in Booroola x Romney ewes which have a major gene influencing their ovulation rate. J Reprod Fertil 73:109–120[Abstract/Free Full Text]
  31. McNatty K, Lun S, Heath D, Ball K, Smith P, Hudson NL, McDiarmid J, Gibb M, Henderson KM 1986 Differences in ovarian activity between Booroola x Merino ewes which were homozygous, heterozygous and non-carriers of a major gene influencing their ovulation rate. J Reprod Fertil 77:193–205[Abstract/Free Full Text]
  32. Driancourt M, Cahill L, Bindon B 1985 Ovarian follicular populations and preovulatory enlargement in Booroola and Merino ewes. J Reprod Fertil 73:93–107[Abstract/Free Full Text]
  33. McNatty K, Hudson N, Henderson K, Gibb M, Morrison L, Ball K, Smith P 1987 Differences in gonadotrophin concentrations and pituitary responsiveness to GnRH between Booroola ewes which were homozygous (FF), heterozygous (F+) and non-carriers (++) of a major gene influencing their ovulation rate. J Reprod Fertil 80:577–588[Abstract/Free Full Text]
  34. Boulton M, Haley C, Springbett A, Webb R 1995 The effect of the Booroola (FecB) gene on peripheral FSH concentrations and ovulation rates during oestrus, seasonal anoestrus and on FSH concentrations following ovariectomy in Scottish Blackface ewes. J Reprod Fertil 103:199–207[Abstract/Free Full Text]
  35. Campbell BK, Baird DT, Souza CJ, Webb R 2003 The FecB (Booroola) gene acts at the ovary: in vivo evidence. Reproduction 126:101–111[Abstract]
  36. Campbell B, Scaramuzzi R, Webb R 1996 Induction and maintenance of oestradiol and immuno-reactive inhibin production with FSH by ovine granulosa cells cultured in serum free media. J Reprod Fertil 106:7–16[Abstract/Free Full Text]
  37. Campbell B, Baird D, Webb R 1998 The effects of dose of LH on androgen production and luteinization of ovine theca cells cultured in a serum-free system. J Reprod Fertil 112:69–77[Abstract/Free Full Text]
  38. Haley C 1990 The Booroola gene in the UK, origins, research and development. In: Elsen JM, Bodin L, Thimonier J, eds. Major genes for reproduction in sheep. Paris: Institut National de la Recherche Agronomique; 33–38
  39. Campbell B, Telfer E, Webb R, Baird D 2000 Ovarian autografts in sheep as a model for studying folliculogenesis. Mol Cell Endocrinol 163:131–139[CrossRef][Medline]
  40. Engelhardt H, Smith K, McNeilly A, Baird D 1993 Expression of messenger ribonucleic acid for inhibin subunits and ovarian secretion of inhibin and estradiol at various stages of the sheep estrous cycle. Biol Reprod 49:281–294[Abstract]
  41. Souza C, Campbell B, Baird D, Webb R 1997 Secretion of inhibin A and follicular dynamics throughout the oestrous cycle in sheep with and without the Booroola gene (FecB). Endocrinology 138:5333–5340[Abstract/Free Full Text]
  42. Glister C, Richards SL, Knight PG 2005 Bone morphogenetic proteins (BMP) -4, -6, and -7 potently suppress basal and luteinizing hormone-induced androgen production by bovine theca interna cells in primary culture: could ovarian hyperandrogenic dysfunction be caused by a defect in thecal BMP signaling? Endocrinology 146:1883–1892[Abstract/Free Full Text]
  43. Eppig JJ 2001 Oocyte control of ovarian follicular development and function in mammals. Reproduction 122:829–838[Abstract]
  44. Dugan KJ, Campbell BK, Skinnner A, Armstrong DG, Webb R 2004 Expression of bone morphogenetic protein-6 (BMP-6) in the bovine foetal ovary at different stages of gestation. Reprod Abstr Ser 31:O46
  45. Fabre S, Pierre A, Pisselet C, Mulsant P, Lecerf F, Pohl J, Monget P, Monniaux D 2003 The Booroola mutation in sheep is associated with an alteration of the bone morphogenetic protein receptor-IB functionality. J Endocrinol 177:435–444[Abstract]
  46. Webb R, Campbell B, Garverick H, Gong J, Gutierrez C, Armstrong D 1999 Molecular mechanisms regulating follicular recruitment and selection. J Reprod Fertil Suppl 53:33–48
  47. Campbell B, Baird D 2001 Inhibin A is a FSH-responsive marker of granulosa cell differentiation which has both autocrine and paracrine actions in sheep. J Endocrinol 169:333–345[Abstract]
  48. Campbell B 1988 Factors affecting ovulation rate in sheep and cattle. Ph.D. thesis, University of Sydney, Sydney, Australia
  49. Campbell BK, Sharma S, Shimasaki S, Baird DT, Effect of AMH, BMP-15 and GDF-9 on FSH-induced differentiation of sheep granulosa cells. Proc 38th Annual Meeting of the Study of Reproduction, 2005, p 247 (Abstract T728)
  50. McNeilly A, Picton H, Campbell B, Baird D 1991 Gonadothrophic control of follicle growth in the ewe. J Reprod Fertil Suppl 43:177–186[Medline]
  51. Marsters P, Kendall NR, Campbell BK 2003 Temporal relationships between FSH receptor, type 1 insulin-like growth factor receptor, and aromatase expression during FSH-induced differentiation of bovine granulosa cells maintained in serum-free culture. Mol Cell Endocrinol 203:117–127[CrossRef][Medline]



This article has been cited by other articles:


Home page
 Biol. Reprod.Home page
B.K. Campbell, N.R. Kendall, and D.T. Baird
Effect of Direct Ovarian Infusion of Bone Morphogenetic Protein 6 (BMP6) on Ovarian Function in Sheep
Biol Reprod, November 1, 2009; 81(5): 1016 - 1023.
[Abstract] [Full Text] [PDF]

Home page
 ReproductionHome page
C. Ruoss, A. Tadros, T. O'Shea, J. McFarlane, and G. Almahbobi
Ovarian follicle development in Booroola sheep exhibiting impaired bone morphogenetic protein signalling pathway
Reproduction, October 1, 2009; 138(4): 689 - 696.
[Abstract] [Full Text] [PDF]

Home page
 ReproductionHome page
A. R Kayani, C. Glister, and P. G Knight
Evidence for an inhibitory role of bone morphogenetic protein(s) in the follicular-luteal transition in cattle
Reproduction, January 1, 2009; 137(1): 67 - 78.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. J. McTavish, M. Jimenez, K. A. Walters, J. Spaliviero, N. P. Groome, A. P. Themmen, J. A. Visser, D. J. Handelsman, and C. M. Allan
Rising Follicle-Stimulating Hormone Levels with Age Accelerate Female Reproductive Failure
Endocrinology, September 1, 2007; 148(9): 4432 - 4439.
[Abstract] [Full Text] [PDF]

Home page
 ReproductionHome page
S. L Al-Musawi, R. T Gladwell, and P. G Knight
Bone morphogenetic protein-6 enhances gonadotrophin-dependent progesterone and inhibin secretion and expression of mRNA transcripts encoding gonadotrophin receptors and inhibin/activin subunits in chicken granulosa cells
Reproduction, August 1, 2007; 134(2): 293 - 306.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Campbell, B. K.
Right arrow Articles by Baird, D. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Campbell, B. K.
Right arrow Articles by Baird, D. T.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals